# A Study of PHN-012 in Patients With Advanced Solid Tumors

> **NCT07127874** · PHASE1 · RECRUITING · sponsor: **Pheon Therapeutics** · enrollment: 165 (estimated)

## Conditions studied

- Colon Cancer
- Pancreatic Cancer
- Lung Cancer (NSCLC)
- Advanced Cancer
- Advanced Solid Tumors

## Interventions

- **DRUG:** PHN-012

## Key facts

- **NCT ID:** NCT07127874
- **Lead sponsor:** Pheon Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-23
- **Primary completion:** 2027-09
- **Final completion:** 2028-05
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07127874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07127874, "A Study of PHN-012 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07127874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*